There are serious adverse reactions!
Antipyretics Analgin injection is banned
Yangcheng Evening News reporter Chen Zeyun reported: On March 17, the State Food and Drug Administration issued an announcement saying that the production, sales, and use of Aninin injection, dimethylpyrimidine preparations, hydroxybutrazine tablets and other varieties in China were stopped, and drug registration was cancelled. The certificate, meanwhile, amended the manuals for varieties such as Anai recent films, requiring that they be banned for young children under the age of 18.
Among them, Analgin is a pyrazolone antipyretic and analgesic, that is, an antipyretic. The drug has been on the market earlier in China, and its preparations include oral preparations, injections, and nasal drops.
Since the 1920s, the drug has become popular all over the world as an over-the-counter antipyretic drug. However, subsequently, the drug frequently had serious adverse reactions. For example, the drug could cause granulocytopenia with a long period of time, the incidence rate was about 1.1%. Currently, the United States, Japan, Australia and many other countries have successively banned An Najin.
The State Administration of Drug Administration pointed out that, after evaluation by the State Drug Administration, it was concluded that Anaijin Injection, Anaijin Chlorpromazine Injection, Pediatric Anaijin Enema, Anaijin Drops, Anaijin Nasal Drops, There are serious allergic reactions such as severe allergic reactions, agranulocytosis and other serious adverse reactions such as analginine solution tablets for nasal drops, pediatric antipyretic suppository, the risks are greater than the benefits, and alternative medicines are available clinically. Article 13: The drug registration certificate shall be cancelled.
It is worth noting that due to the clinical value of oral preparations such as Anaijin tablets, the FDA has the risk of adopting revised instructions for Anaijin Tablets, Zhongganling Tablets, Zhongganling Capsules, and Compound Qinghao Annan Tablets. Control measures, increase safety warning information, according to the revised announcement, the above drugs are banned in adolescents and children under the age of 18, while women in late pregnancy are also banned.